Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Income from Non-Controlling Interests (2017 - 2020)

Myriad Genetics (MYGN) has disclosed Income from Non-Controlling Interests for 3 consecutive years, with -$100000.0 as the latest value for Q2 2020.

  • On a quarterly basis, Income from Non-Controlling Interests changed 0.0% to -$100000.0 in Q2 2020 year-over-year; TTM through Mar 2021 was -$100000.0, a 0.0% change, with the full-year FY2020 number at -$100000.0, up 50.0% from a year prior.
  • Income from Non-Controlling Interests was -$100000.0 for Q2 2020 at Myriad Genetics, roughly flat from -$100000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of -$100000.0 in Q1 2018 to a low of -$100000.0 in Q1 2018.
  • A 3-year average of -$100000.0 and a median of -$100000.0 in 2018 define the central range for Income from Non-Controlling Interests.
  • Biggest YoY gain for Income from Non-Controlling Interests was 0.0% in 2020; the steepest drop was 0.0% in 2020.
  • Myriad Genetics' Income from Non-Controlling Interests stood at -$100000.0 in 2018, then changed by 0.0% to -$100000.0 in 2019, then changed by 0.0% to -$100000.0 in 2020.
  • Per Business Quant, the three most recent readings for MYGN's Income from Non-Controlling Interests are -$100000.0 (Q2 2020), -$100000.0 (Q2 2019), and -$100000.0 (Q3 2018).